key: cord-0771731-z1w4nztk
authors: Forero‐Peña, David A.; Carrión‐Nessi, Fhabián S.; Mendoza‐Millán, Daniela L.; Omaña‐Ávila, Óscar D.; Mejía‐Bernard, Mario D.; Camejo‐Ávila, Natasha A.; Flora‐Noda, David M.; Velásquez, Viledy L.; Chacón‐Labrador, Fabián R.; Doval‐Fernández, Juan M.; Maricuto, Andrea L.; Grillet, María E.; Hernández‐Villena, Juan V.; Vincenti‐González, María F.; Paniz‐Mondolfi, Alberto E.; Orejas, José; Rodríguez, Verónica I.; Contreras, Mariana B.; Guevara, Rafael N.; Carballo, Martín; Caldera, Jocays; Redondo, María C.; Landaeta, María E.
title: First wave of COVID‐19 in Venezuela: Epidemiological, clinical, and paraclinical characteristics of first cases
date: 2021-11-16
journal: J Med Virol
DOI: 10.1002/jmv.27449
sha: 9e6949d098ed21e468cc33287eafe7366a76e919
doc_id: 771731
cord_uid: z1w4nztk

The coronavirus disease 2019 (COVID‐19) pandemic has particularly affected countries with weakened health services in Latin America, where proper patient management could be a critical step to address the epidemic. In this study, we aimed to characterize and identify which epidemiological, clinical, and paraclinical risk factors defined COVID‐19 infection from the first confirmed cases through the first epidemic wave in Venezuela. A retrospective analysis of consecutive suspected cases of COVID‐19 admitted to a sentinel hospital was carried out, including 576 patient cases subsequently confirmed for severe acute respiratory syndrome coronavirus 2 infection. Of these, 162 (28.1%) patients met the definition criteria for severe/critical disease, and 414 (71.2%) were classified as mild/moderate disease. The mean age was 47 (SD 16) years, the majority of which were men (59.5%), and the most frequent comorbidity was arterial hypertension (23.3%). The most common symptoms included fever (88.7%), headache (65.6%), and dry cough (63.9%). Severe/critical disease affected mostly older males with low schooling (p < 0.001). Similarly, higher levels of glycemia, urea, aminotransferases, total bilirubin, lactate dehydrogenase, and erythrocyte sedimentation rate were observed in severe/critical disease patients compared to those with mild/moderate disease. Overall mortality was 7.6% (44/576), with 41.7% (28/68) dying in hospital. We identified risk factors related to COVID‐19 infection, which could help healthcare providers take appropriate measures and prevent severe clinical outcomes. Our results suggest that the mortality registered by this disease in Venezuela during the first epidemic wave was underestimated. An increase in fatalities is expected to occur in the coming months unless measures that are more effective are implemented to mitigate the epidemic while the vaccination process is ongoing.

unless measures that are more effective are implemented to mitigate the epidemic while the vaccination process is ongoing. Currently, mortalities attributable to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the region amount to almost 2.5 million people. As the deployment of vaccines continues to advance at a slower rate than that of developed countries, the pandemic will continue to affect and generate excess morbidity and mortality in those countries with weakened health services, economic and political instabilities, humanitarian crises, and deep social inequalities. 2, 3 The impact of COVID-19 in Venezuela is expected to be high given the complex humanitarian crisis that the country is experiencing. 4, 5 However, this same socioeconomic crisis has influenced the epidemic to initially develop slowly while displaying a geographically fragmented pattern. 6 A combination of various factors, such as previous air traffic restrictions, severe gasoline deficiency, and the establishment of an early quarantine determined a low initial inflow of imported cases, which significantly impacted mobility within the country, something that delayed the spread of the virus and mitigated its effect during the first epidemic wave that peaked in mid-August 2020. 6 As of diagnostic capacity that has governed the management of the epidemic since its inception suggests that this epidemic is 5 to 7 times more intense than what is officially reported. 6 At the regional level, Venezuela is one of the countries with the lowest diagnostic coverage (<25 tests per 1000 inhabitants), and with the lowest vaccination coverage (<22%), which raises doubts about the country's capacity to carry out an adequate surveillance and intervention program of SARS-CoV-2 transmission in the near future. 6, 7 This low coverage is more related to the slow response of the country to obtain an adequate supply of vaccines 7 than to a low vaccination intention. 8 Currently, the incidence of the disease continues to be underestimated, although the health system has begun to overflow under the unfolding of a second major epidemic wave that is now progressing more intensely throughout the country. The inability of the public health system in Venezuela to face the demands of the COVID-19 pandemic is evidenced by the reduction in the number of hospital beds for critical patient care according to estimates from the National Survey of Venezuelan Hospitals. 9 The massive exodus of Venezuelans to neighboring countries due to the humanitarian crisis has increased as a consequence of the current pandemic. 10, 11 Similarly, thousands of these migrants have been forced to return when the pandemic has hit the region's economy, 12 adding to the continuous unregistered informal crossing that occurs across borders from Colombia and Brazil. 13 This massive and continuous transit of people can enhance introduction and transmission events, while the uncontrolled spread of the virus can further complicate the management of the pandemic in already vulnerable countries across the region. 5, 7, 14 The first epidemic wave of COVID-19 in Venezuela displayed significant geographic heterogeneity, with most cases concentrated in the north-central region. 6 The first cases were notified on March 13, 2020, almost three weeks later Brazil detected the first case in the region 15 and one week after the first report from Colombia. 16 The first diagnosed case was that of a 41-year-old woman returning from Europe who attended the University Hospital located in Caracas (capital city of the country). As of August 2, 2020, 44 899 cases and 462 deaths had been reported in Caracas with these figures representing around 15% and 13% of the total number of cases and deaths reported in Venezuela, respectively.

Proper management of a patient's critical, chronic, and comorbid conditions is a critical step in tackling this epidemic.

Hence, characterizing and identifying people with a higher risk for developing critical and severe COVID-19 is crucial for the design of strategies seeking to protect or selectively vaccinate. As an example, public health interventions to modify comorbidities or treatment of COVID-19 early in the course of the disease could have a positive impact on viral infection overall outcome in vulnerable countries of the Latin America region. 17 To date, reports on the epidemiological and clinical characteristics of this pandemic in the region is very limited. [18] [19] [20] [21] [22] For the case of Venezuela, there is no data integrated into a national surveillance system that allows identifying the characteristics or results of hospital admissions for COVID-19 and the impact that the pandemic has had since its origin on the national system of health.

The main objective of this study is to characterize and identify 

We retrospectively analyzed the confirmed COVID-19 (according WHO guidelines) 23 

After the patients were interviewed and considered to meet criteria for suspected COVID-19 cases, a standardized questionnaire was applied by trained postgraduate residents to collect demographic and epidemiological information (including recent travel history or contact with confirmed/suspected COVID-19 cases), medical comorbidities, and data on 25 symptoms were collected. A detailed physical examination (including pulse and respiratory rate, blood pressure, and temperature) was performed. Follow-up calls to evaluate the clinical outcome of the patients were performed during 28 days by health professionals not linked to this project as part of their standard of care treatment for patients with COVID-19. The severity of the disease was established as mild, moderate, severe, and critical, according to the National Institute of Health guidelines. 24 For analysis purposes, cases of mild/moderate disease (oxygen saturation ≥ 94%) and severe/critical cases (oxygen saturation <94%) were grouped.

According to guidelines of the Infectious Diseases Department of the University Hospital of Caracas, a 5-ml sample of blood by venipuncture was taken from each patient, which was distributed in a tube containing ethylenediaminetetraacetic acid (3 ml) and a tube without anticoagulant (2 ml) for completing blood count and blood chemistry (urea, creatinine, glycemia, electrolytes, aminotransferases, and lactic dehydrogenase), respectively. Radiological evaluation was limited due to a lack of technical equipment during the study period.

The nasopharyngeal samples collected were stored at 2-8°C and processed by the diagnostic reference laboratory in the country.

Data analysis considered descriptions of the characteristics of the sample studied by using central tendency and dispersion measures (mean, standard deviation, median, and interquartile range).

The distribution of the parameters was evaluated using the Kolmogorov-Smirnov test. Parametric tests were used and when normality was not evident the data were subjected to nonparametric tests. The data were analyzed by Student's t-test, Mann-Whitney U test, Pearson's χ 2 test, and Fisher's exact test, as appropriate.

A p < 0.05 was considered significant. The Table 1) .

Compared with mild/moderate disease, severe/critical disease patients were often elderly males with no schooling or only elementary school-level, married or widowed, and economically independent or unemployed (p < 0.001).

The most frequent comorbidity was arterial hypertension (23.3%, n = 134), followed by asthma (8.2%, n = 47), and diabetes mellitus (7.3%, n = 42); whereas six patients had human immunodeficiency virus. Severe/critical disease patients exhibited a higher proportion of comorbidities, such as hypertension, diabetes, and chronic obstructive pulmonary disease (p < 0.001). In relation to disease severity, there were no significant differences between those who smoke or smoked and those who had never smoked. However, within the group that smoke or smoked, a greater number of cigarettes per day and more year's smoking was associated with severe/critical disease ( 

Of the 162 patients with severe/critical disease criteria, only 68 (42%) patients were hospitalized in the University Hospital of Caracas, of which 28 died (in-hospital mortality of 41.7%), and 94 (58%)

were referred to another institution, due to lack of bed availability.

Finally, a total of 44 of the 576 (7.6%) that were followed during the study period died.

To the best of our knowledge, our study is the first to assess the epidemiological, clinical, and paraclinical characteristics of COVID-19 patients in Venezuela. We retrospectively analyzed data from 576 patients with confirmed SARS-CoV-2 infection by RT-PCR, who Here, the mean age and male predominance of patients confirmed with SARS-CoV-2 infection were similar to those reported by other authors in Ecuador, 21 Peru, 25 Chile, 26 Mexico, 27 Europe, 28 and

China. 29, 30 Likewise, advanced age was associated with a worse outcome of the disease, in accordance with other studies. [31] [32] [33] We found a significant association between lower levels of schooling and severe/critical disease, suggesting that the educational level could be a determining factor in the knowledge of the disease and the consultation time in the presence of suspicious symptoms of COVID-19.

This could also be evidenced in bigger cohort studies from the United States where the mortality in people without a high school degree and black residents was higher when compared with the rest of the population. 34 This notorious difference could be based mainly on the possibility of access to a healthcare institution and education regarding the alarming symptoms, which the patient should be aware of to get medical attention. 34, 35 In our study, severe/critical disease patients had a higher pro- severe disease in China. 29, 56, 57 Elevation of LDH has been identified as a marker of lung damage in previous studies, 58 with a direct relationship between the decrease in LDH and the clearance of viral mRNA, associating its decrease with a better prognosis when faced with disease, 53 and its increase as a risk factor for death in COVID-19

patients. 55 Likewise, the elevation of liver enzymes has been linked to damage to other organs and mediation of systemic response in severe disease. 29 Hyponatremia, hypernatremia, hypokalemia, hypocalcemia, and hypochloremia are the most common electrolyte disorders among COVID-19 patients, 59 each one associated with higher intensive care unit requirement, mechanical ventilation requirement, and mortality. 59 The study of these laboratory parameters not only guides us in the diagnosis and therapy but also allows inferring disease prognosis. 54 Allocating healthcare resources for severe/critical disease patients has represented a difficult ethical dilemma during this pandemic as shortages for beds or equipment has been increasing worldwide. 21 accelerated, the death toll due to COVID-19 is expected to increase in the following months.

We thank patients, healthcare workers from Infectious Disease Department, Caracas University Hospital, and research staff involved in the work. This study did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

The authors declare that there are no conflict of interests.

The study protocol was reviewed and approved by the National Center for Bioethics (CENABI, in Spanish) of Venezuela (CIBI-CENABI-08/2020). The information was collected according to the Helsinki Convention and the Venezuelan regulations for this kind of research.

Grillet conceived and designed the study

Contreras collected clinical data

Paniz-Mondolfi, and José Orejas analyzed and interpreted the data

Paniz-Mondolfi, and José Orejas wrote the manuscript

Landaeta critically reviewed the manuscript. All authors reviewed and approved the final

José Orejas

Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset

COVID-19 in Latin America-emergency and opportunity

Latin American healthcare systems in times of pandemic

Venezuela's humanitarian crisis, resurgence of vector-borne diseases, and implications for spillover in the region

The arrival of SARS-CoV-2 in Venezuela

Signatures of the Venezuelan humanitarian crisis in the first wave of COVID-19: fuel shortages and border migration

Venezuela is collapsing without COVID-19 vaccines

Cross-sectional analysis of COVID-19 vaccine intention, perceptions and hesitancy across Latin America and the Caribbean

Encuesta Nacional de Hospitales

Venezuelan migrants "struggling to survive" amid COVID-19

The unfolding migrant crisis in Latin America

Recommendations for the response against COVID-19 in migratory contexts under a closed border: The case of Colombia

Sociodemographic Profiles and the Causes of Regular Venezuelan Emigration

SARS-CoV-2 in transit: characterization of SARS-CoV-2 genomes from Venezuelan migrants in Colombia

COVID-19 in Latin America: the implications of the first confirmed case in Brazil

The arrival and spread of SARS-CoV-2 in Colombia

Understanding the potential impact of different drug properties on SARS-CoV-2 transmission and disease burden: a modelling analysis

COVID-19 en Latinoamérica: una revisión sistemática de la literatura y análisis bibliométrico

Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil

Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study

Epidemiological, socio-demographic and clinical features of the early phase of the COVID-19 epidemic in Ecuador

Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data

Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance

Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines

Risk of death by age and gender from CoVID-19 in Peru

A comprehensive analysis of COVID-19 impact in Latin America

Outcomes of patients with COVID-19 in the intensive care unit in Mexico: A multicenter observational study

Sex and age differences in COVID-19 mortality in Europe

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan

Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 -United States

Socio-economic status and COVID-19-related cases and fatalities

COVID-19 and racial/ethnic disparities in health risk, employment, and household composition

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan

Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China

Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: Results from the Brazilian COVID-19 registry

Clinical presentation and outcomes of the first patients with COVID-19 in Argentina: Results of 207079 cases from a national database

Clinical Characteristics of Covid-19 in New York City

Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia

Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort

Clinical characteristics of coronavirus disease 2019 in China

Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process

Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China

Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment

Tracing new clinical manifestations in patients with COVID-19 in Chile and its potential relationship with the SARS-CoV-2 divergence

The clinical and chest CT features associated with severe and critical COVID-19 pneumonia

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Comorbidities and multi-organ injuries in the treatment of COVID-19

Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients

Laboratory findings in COVID-19 diagnosis and prognosis

Caracterización clínica y del hemograma de pacientes con neumonía por COVID-19 en Veracruz

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

The actual role of LDH as tumor marker, biochemical and clinical aspects

Fluid and electrolyte disturbances in COVID-19 and their complications

A framework for rationing ventilators and critical care beds during the COVID-19 pandemic

Hospital surge capacity in a tertiary emergency referral centre during the COVID-19 outbreak in Italy

Clinical outcomes of patients hospitalized for COVID-19 and evidence-based on the pharmacological management reduce mortality in a region of the Colombian Caribbean

Epidemiology, outcomes, and associated factors of coronavirus disease 2019 (COVID-19) reverse transcriptase polymerase chain reactionconfirmed cases in the San Pedro Sula metropolitan area

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study

Patient characteristics and outcomes of 11 721 patients with coronavirus disease 2019 (COVID-19) hospitalized across the United States

The epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): an observational study

First wave of COVID-19 in Venezuela: Epidemiological, clinical, and paraclinical characteristics of first cases